After an over decade-long discourse amongst interested stakeholders, on October 3, 2023, FDA unveiled its proposed rule and policy to increase oversight over LDTs.
On December 29, 2022, President Biden signed into law the Consolidated Appropriations Act, 2023, a $1.7 trillion omnibus that will fund the federal government through the remainder of fiscal.
The vaccine is still available under emergency use authorization, and the CDC has already made a preferential recommendation for the mRNA vaccines over J&J’s.